Dankelman J, Van der Ploeg C P, Spaan J A
Department of Medical Physics and Informatics, University of Amsterdam, The Netherlands.
Am J Physiol. 1994 May;266(5 Pt 2):H1715-21. doi: 10.1152/ajpheart.1994.266.5.H1715.
The role of blocking ATP-sensitive potassium (KATP) channels by glibenclamide on the dynamic responses of coronary resistance to abrupt changes in perfusion pressure and heart rate was investigated. The left main coronary artery of the open-chest anesthetized goat was perfused with constant pressure (Pp). Pp and arterial flow were averaged per beat, and their ratio was calculated as index of coronary resistance. Responses of resistance index after heart rate (HR) and Pp changes before and after administration of glibenclamide were compared. Their rate of change was quantified by t50, the required time to obtain half of the complete response. During control, t50 for the dilating response induced by a decrease in Pp or increase in HR was 3.8 +/- 0.2 and 6.2 +/- 0.5 (SE) s, respectively. With glibenclamide these values were 24.4 +/- 1.6 and 14.9 +/- 2.1 s. For the constricting response, the numbers for control were 5.8 +/- 0.3 (increase Pp) and 7.2 +/- 0.8 (decrease HR) s. With glibenclamide these values were 22.1 +/- 1.5 and 16.0 +/- 2.9 s. The steady-state adjustment of coronary flow was not altered by glibenclamide. It was concluded that glibenclamide has a minor effect on coronary flow control but reduces the rate of change of coronary resistance index up to a factor of four. Because glibenclamide is supposed to act on KATP channels, it may be concluded that these channels play a major role in the dynamics of coronary blood flow regulation.
研究了格列本脲阻断三磷酸腺苷敏感性钾(KATP)通道对冠状动脉阻力随灌注压和心率突然变化的动态反应的作用。对开胸麻醉山羊的左冠状动脉进行恒压(Pp)灌注。Pp和动脉血流按每搏平均,并计算它们的比值作为冠状动脉阻力指数。比较了格列本脲给药前后心率(HR)和Pp变化后阻力指数的反应。其变化率通过t50量化,即获得完整反应一半所需的时间。在对照期间,Pp降低或HR增加引起的舒张反应的t50分别为3.8±0.2和6.2±0.5(SE)秒。使用格列本脲时,这些值分别为24.4±1.6和14.9±2.1秒。对于收缩反应,对照时的数值为5.8±0.3(Pp增加)和7.2±0.8(HR降低)秒。使用格列本脲时,这些值分别为22.1±1.5和16.0±2.9秒。格列本脲未改变冠状动脉血流的稳态调节。得出的结论是,格列本脲对冠状动脉血流控制的影响较小,但可将冠状动脉阻力指数的变化率降低至四倍。由于格列本脲被认为作用于KATP通道,因此可以得出结论,这些通道在冠状动脉血流调节动力学中起主要作用。